Is 7-OH Legal in Tennessee?

If you’ve been using kratom or following Tennessee’s kratom legislation, you’ve probably come across the term 7-OH — or 7-hydroxymitragynine. And you may have noticed that the conversation around kratom legality in Tennessee increasingly centers on this specific compound rather than kratom as a whole.

Here’s a plain-language breakdown of what 7-OH is, what Tennessee law says about it, and what this means if you’ve been using it.

Table of Contents

• What Is 7-OH?
• What Tennessee Law Says About 7-OH
• How 7-OH Is Different From Regular Kratom
• Why the 7-OH Ban Matters for Kratom Users
• If You’ve Been Using 7-OH Regularly
• Frequently Asked Questions
• Next Steps

Is 7-OH Legal in Tennessee?

What Is 7-OH?

7-hydroxymitragynine — commonly called 7-OH — is an alkaloid found in the kratom plant (Mitragyna speciosa). It occurs naturally in kratom leaves in very small concentrations, typically less than 2% of the plant’s alkaloid content. However, it’s also produced synthetically and concentrated into products sold separately from traditional kratom powder or capsules.

7-OH is significantly more potent than mitragynine, the primary alkaloid in kratom. It binds strongly to opioid receptors in the brain — more so than standard kratom — which is why it’s associated with stronger effects and a higher potential for dependence. Research published on PubMed has characterized 7-OH as a potent opioid agonist, which is central to why legislators and regulators have focused on it specifically.

Products marketed as “7-OH” or “7-hydroxymitragynine” are often sold in shot, tablet, or tincture form — distinct from traditional kratom powder — and typically contain concentrated or synthetic versions of the compound.

What Tennessee Law Says About 7-OH

As of July 1, 2026, 7-hydroxymitragynine is effectively banned in Tennessee. The legislation that took effect on that date targeted not just kratom broadly, but specifically addressed 7-OH as a controlled or regulated substance — reflecting the legislature’s concern about its opioid-like potency and the concentrated products being sold under that name.

This means that the sale, distribution, and possession of products containing 7-OH — including shots, tinctures, tablets, and other concentrated forms — is no longer legal in the state. The law treats concentrated 7-OH products differently from traditionally prepared kratom in some respects, but the practical result for most users is that the 7-OH products they’ve been purchasing are no longer available through legal channels in Tennessee.

For a full breakdown of how the July 1 legislation affects kratom users in recovery, see our post on what Tennessee’s kratom ban means and what the new kratom law means for people in recovery.

How 7-OH Is Different From Regular Kratom

Understanding the distinction between 7-OH and standard kratom matters — both legally and clinically.

Traditional kratom powder and capsules are made from dried and ground kratom leaves. The primary active alkaloid is mitragynine, with 7-OH present naturally in small amounts. The effects of traditional kratom vary significantly depending on dose and strain.

Concentrated or synthetic 7-OH products are a different category. They isolate and amplify the compound most associated with opioid-like effects — which is why they tend to produce stronger effects at smaller quantities, carry a higher dependence risk, and attracted specific regulatory attention. SAMHSA’s resources on substance dependence describe how potency and route of administration affect dependence risk — both of which are relevant factors with concentrated 7-OH products.

People who used 7-OH products regularly often report stronger withdrawal symptoms than those who used traditional kratom powder, consistent with the compound’s higher opioid receptor activity.

Why the 7-OH Ban Matters for Kratom Users

For people who were using 7-OH regularly — whether for pain management, mood, energy, or because it had become a dependency — the sudden loss of access is a real clinical event, not just a legal technicality.

Unlike opioid medications, which are regulated and can be tapered under medical supervision, 7-OH products existed in a legal gray area that meant most users had no medical relationship around their use. Now that the product is banned, people who were dependent on it are facing withdrawal without the clinical infrastructure that typically exists for regulated substances.

7-OH withdrawal can include significant physical and psychological symptoms — anxiety, irritability, muscle aches, insomnia, nausea, and strong cravings. NIMH’s guidance on substance dependence notes that abrupt discontinuation of opioid-active compounds without support significantly increases discomfort and risk of relapse to other substances. Having clinical support during this transition matters.

If you were also using traditional kratom alongside 7-OH products, our guide on how to taper off kratom covers strategies that may be relevant to your situation, with the caveat that 7-OH dependence specifically warrants a conversation with a clinician.

If You’ve Been Using 7-OH Regularly

If 7-OH was part of your daily routine — even if it didn’t feel like a substance use problem — losing access abruptly is worth taking seriously. A few things worth knowing:

Withdrawal is real and manageable with support. The symptoms associated with 7-OH discontinuation are consistent with opioid withdrawal — uncomfortable but manageable, especially with clinical support. You don’t have to white-knuckle it alone. SAMHSA’s medication-assisted treatment resources describe how medications like buprenorphine can ease opioid withdrawal symptoms — options worth discussing with a provider.

This is a reasonable moment to evaluate your relationship with the substance. For many people, the ban has created an unwanted but useful pause — a chance to assess how dependent they had become and whether they want to find another substance to replace it or address the underlying need differently.

Treatment is available and doesn’t require that you’ve hit rock bottom. Our Intensive Outpatient Program treats substance use — including kratom and opioid-active compound dependence — in a structured outpatient setting. You don’t need to be in crisis to reach out. If the ban has disrupted your routine and you’re not sure what to do next, that’s a reasonable reason to call.

Co-occurring conditions are common and worth addressing. Many people who used 7-OH regularly were managing underlying anxiety, depression, or chronic pain. Losing the substance that was managing those symptoms — even imperfectly — can bring them back to the surface. Addressing both the dependence and the underlying condition simultaneously produces better outcomes than addressing either alone. Our post on anxiety and addiction co-occurring covers how integrated treatment works.

Frequently Asked Questions

Next Steps

If the 7-OH ban has left you navigating withdrawal, uncertainty about what to do next, or a renewed awareness of how dependent you had become — our team in Brentwood can help. We treat substance use including kratom and opioid-active compound dependence in a structured outpatient setting, without judgment and without requiring that you’ve already decided to stop.

Reach out here to start a conversation with our admissions team. You can also learn more about our IOP and PHP programs, or visit our insurance page to understand what your coverage looks like before your first call.